$9.85
-0.28-2.76%
al cierre: Nov 17, 4:00 PM EST
$9.85
N/A
After hour: 5:25 PM EST

Sagimet Biosciences (SGMT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.31 | $-0.26 | -19.2 % |
| Q2 | Aug 11, 2026 | $-0.26 | $-0.27 | 3.70 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.36 | 8.33 % |
| Q4 | Mar 11, 2026 | $-0.29 | $-0.41 | 29.3 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | Mar 11, 2026 | $0 | $1.25M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.26 | $-0.27 | $-0.36 | $-0.41 |
| Actual | $-0.31 | $-0.26 | $-0.33 | $-0.29 |
| Surprise | -19.2% | +3.70% | +8.33% | +29.3% |
| Revenue | ||||
| Estimate | — | — | — | $1.3M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.31 | $-0.30 | $-0.32 | $-0.34 |
| Revenue | ||||
| Consensus | — | $1.2M | — | — |